Proto Labs Inc (PRLB) Receives Consensus Recommendation of “Hold” from Analysts

Shares of Proto Labs Inc (NYSE:PRLB) have been assigned an average recommendation of “Hold” from the six research firms that are presently covering the firm, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $100.33.

PRLB has been the topic of several recent analyst reports. Zacks Investment Research upgraded shares of Proto Labs from a “hold” rating to a “buy” rating and set a $120.00 target price on the stock in a report on Saturday, January 13th. Piper Jaffray Companies restated a “hold” rating and issued a $84.00 target price on shares of Proto Labs in a report on Thursday, December 14th. Finally, Craig Hallum set a $92.00 target price on shares of Proto Labs and gave the stock a “hold” rating in a report on Monday, November 27th.

Proto Labs (PRLB) traded down $1.70 during mid-day trading on Friday, hitting $105.90. 509,498 shares of the company’s stock traded hands, compared to its average volume of 155,453. The stock has a market capitalization of $2,770.00, a P/E ratio of 54.87, a PEG ratio of 2.43 and a beta of 1.08. Proto Labs has a 52-week low of $48.00 and a 52-week high of $113.05.

Proto Labs (NYSE:PRLB) last posted its quarterly earnings results on Thursday, February 8th. The industrial products company reported $0.53 EPS for the quarter, topping the consensus estimate of $0.48 by $0.05. Proto Labs had a net margin of 15.03% and a return on equity of 12.22%. The firm had revenue of $94.18 million for the quarter, compared to the consensus estimate of $92.20 million. During the same period last year, the firm posted $0.41 earnings per share. The business’s revenue was up 30.2% compared to the same quarter last year. analysts expect that Proto Labs will post 2.19 earnings per share for the current fiscal year.

In other news, Director Rainer Gawlick sold 1,500 shares of the firm’s stock in a transaction that occurred on Tuesday, November 21st. The shares were sold at an average price of $90.31, for a total value of $135,465.00. Following the transaction, the director now owns 6,925 shares in the company, valued at $625,396.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP John B. Tumelty sold 13,556 shares of the firm’s stock in a transaction that occurred on Wednesday, November 22nd. The stock was sold at an average price of $92.07, for a total transaction of $1,248,100.92. The disclosure for this sale can be found here. Insiders sold 19,556 shares of company stock worth $1,814,101 in the last 90 days. Company insiders own 7.78% of the company’s stock.

A number of large investors have recently added to or reduced their stakes in the stock. BlackRock Inc. boosted its holdings in Proto Labs by 2.4% in the fourth quarter. BlackRock Inc. now owns 3,053,965 shares of the industrial products company’s stock valued at $314,558,000 after acquiring an additional 72,731 shares in the last quarter. Vanguard Group Inc. boosted its holdings in Proto Labs by 2.7% in the second quarter. Vanguard Group Inc. now owns 2,176,051 shares of the industrial products company’s stock valued at $146,339,000 after acquiring an additional 56,724 shares in the last quarter. New York State Common Retirement Fund boosted its holdings in Proto Labs by 2.1% in the third quarter. New York State Common Retirement Fund now owns 651,475 shares of the industrial products company’s stock valued at $52,313,000 after acquiring an additional 13,206 shares in the last quarter. State Street Corp boosted its holdings in Proto Labs by 5.2% in the second quarter. State Street Corp now owns 595,748 shares of the industrial products company’s stock valued at $40,063,000 after acquiring an additional 29,561 shares in the last quarter. Finally, Conestoga Capital Advisors LLC boosted its holdings in Proto Labs by 16.1% in the fourth quarter. Conestoga Capital Advisors LLC now owns 588,419 shares of the industrial products company’s stock valued at $60,607,000 after acquiring an additional 81,745 shares in the last quarter.

TRADEMARK VIOLATION WARNING: “Proto Labs Inc (PRLB) Receives Consensus Recommendation of “Hold” from Analysts” was first published by American Banking News and is owned by of American Banking News. If you are reading this story on another website, it was illegally stolen and reposted in violation of US and international copyright legislation. The correct version of this story can be accessed at https://www.americanbankingnews.com/2018/02/10/proto-labs-inc-prlb-receives-consensus-recommendation-of-hold-from-analysts.html.

About Proto Labs

Proto Labs, Inc is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company’s geographic segments include the United States, Europe and Japan.

Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply